Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
Authors
Georgiou, Marina
Ntavelou, Panagiota
Stokes, William
Roy, Rajat
Stoilova, Tsvetana
Choo, Josephine A.M.Y.
Martins, Miguel
Ajuh, Paul
Horowitz, Neil
Berkowitz, Ross S.
Elias, Kevin
Publication Date
2022-05-30Journal Title
Oncogene
ISSN
0950-9232
Publisher
Nature Publishing Group UK
Volume
41
Issue
26
Pages
3510-3510
Language
en
Type
Other
This Version
VoR
Metadata
Show full item recordCitation
Georgiou, M., Ntavelou, P., Stokes, W., Roy, R., Maher, G. J., Stoilova, T., Choo, J. A., et al. (2022). Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. [Other]. https://doi.org/10.1038/s41388-022-02354-2
Keywords
Correction, /631/67/1059/2326, /631/67/1517, correction
Identifiers
s41388-022-02354-2, 2354
External DOI: https://doi.org/10.1038/s41388-022-02354-2
This record's DOI: https://doi.org/10.17863/CAM.85929
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.